Atlas Trials

Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway

Clinical trial NCT04200911 · COMPLETED

Trial details

NCT number
NCT04200911
Sponsor
The University of Texas Health Science Center at San Antonio
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Cognitive Impairment, MildAlzheimer Disease
Start date
2020-06-01
Primary completion
2022-01-13
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.